transcriptomic datasets Search Results


90
TAEJOON Pharmaceutical Co xenopus laevis transcriptome dataset

Xenopus Laevis Transcriptome Dataset, supplied by TAEJOON Pharmaceutical Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pmc05079235-48-6-12?v=TAEJOON+Pharmaceutical+Co
Average 90 stars, based on 1 article reviews
xenopus laevis transcriptome dataset - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GeneLAB GmbH mouse left gastrocnemius muscle transcriptomic, proteomic, and epigenomic data
Genelab datasets analyzed in the manuscript.
Mouse Left Gastrocnemius Muscle Transcriptomic, Proteomic, And Epigenomic Data, supplied by GeneLAB GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pmc11166946-3-2-25?v=GeneLAB+GmbH
Average 90 stars, based on 1 article reviews
mouse left gastrocnemius muscle transcriptomic, proteomic, and epigenomic data - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Broad Institute Inc single cell transcriptomics datasets for lgg cancer type
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Single Cell Transcriptomics Datasets For Lgg Cancer Type, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pmc09623737-91-5-14?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
single cell transcriptomics datasets for lgg cancer type - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Hormel Health Labs single-cell rna transcriptome datasets
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Single Cell Rna Transcriptome Datasets, supplied by Hormel Health Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pm37968457-48-23-8?v=Hormel+Health+Labs
Average 90 stars, based on 1 article reviews
single-cell rna transcriptome datasets - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Broad Institute Inc single cell transcriptomics datasets for lgg and skcm cancer types
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Single Cell Transcriptomics Datasets For Lgg And Skcm Cancer Types, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pm36329783-72-5-14?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
single cell transcriptomics datasets for lgg and skcm cancer types - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Genentech inc transcriptomic datasets
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Transcriptomic Datasets, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/10__7554_slash_elife__87930-328-0-27?v=Genentech+inc
Average 90 stars, based on 1 article reviews
transcriptomic datasets - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
METTLER TOLEDO high-resolution time-series transcriptomics datasets
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
High Resolution Time Series Transcriptomics Datasets, supplied by METTLER TOLEDO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pmc04715634-131-18-42?v=METTLER+TOLEDO
Average 90 stars, based on 1 article reviews
high-resolution time-series transcriptomics datasets - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare retinal transcriptomic dataset
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Retinal Transcriptomic Dataset, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pm39637236-414-57-32?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
retinal transcriptomic dataset - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Broad Institute Inc transcriptomics datasets
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Transcriptomics Datasets, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pmc10770621-58-12-16?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
transcriptomics datasets - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Epigenomics ag whole-transcriptome rna sequencing (rna-seq) datasets for human hspcs
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Whole Transcriptome Rna Sequencing (Rna Seq) Datasets For Human Hspcs, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/pmc06079369__mmc2-265-35-42?v=Epigenomics+ag
Average 90 stars, based on 1 article reviews
whole-transcriptome rna sequencing (rna-seq) datasets for human hspcs - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Verlag GmbH whole transcriptome sequencing datasets
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Whole Transcriptome Sequencing Datasets, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/10__1002_slash_adfm__202000893-342-13-3?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
whole transcriptome sequencing datasets - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
TranScrip Partners ahba transcriptomic dataset
PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression <t>for</t> <t>SKCM.</t> ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: <t>LGG,</t> KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Ahba Transcriptomic Dataset, supplied by TranScrip Partners, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+datasets/bio_rxiv__501494-115-3-4?v=TranScrip+Partners
Average 90 stars, based on 1 article reviews
ahba transcriptomic dataset - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Journal: Data in Brief

Article Title: Data on microRNAs and microRNA-targeted mRNAs in Xenopus ectoderm

doi: 10.1016/j.dib.2016.09.054

Figure Lengend Snippet:

Article Snippet: The reference index was prepared from Xenopus laevis transcriptome dataset (courtesy of Taejoon Kwan and Ed Marcotte, UT Austin).

Techniques: Next-Generation Sequencing, Generated, Sequencing

Genelab datasets analyzed in the manuscript.

Journal: Scientific Reports

Article Title: Aging and putative frailty biomarkers are altered by spaceflight

doi: 10.1038/s41598-024-57948-5

Figure Lengend Snippet: Genelab datasets analyzed in the manuscript.

Article Snippet: OSD-101 , Rodent Research-1 (RR1) NASA Validation Flight: Mouse left gastrocnemius muscle transcriptomic, proteomic, and epigenomic data , Galazka J, Globus R "Rodent Research 1", GeneLab, Version 5, http://doi.org/10.26030/sdmt-ae51 , Gastrocnemius muscle.

Techniques: Gene Expression, Expressing, Biomarker Discovery, Irradiation

PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression for SKCM. ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: LGG, KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.

Journal: NAR Cancer

Article Title: Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology

doi: 10.1093/narcan/zcac033

Figure Lengend Snippet: PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression for SKCM. ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: LGG, KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.

Article Snippet: Single cell transcriptomics datasets for LGG and SKCM cancer types were downloaded from the Broad Institute Single Cell Portal under accession number SCP271 ( ) and GEO Accession viewer under accession ID GSE72056 , respectively.

Techniques: Gene Expression, Labeling

TCGA cancer abbreviations. Cancers of interest are highlighted in colors

Journal: NAR Cancer

Article Title: Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology

doi: 10.1093/narcan/zcac033

Figure Lengend Snippet: TCGA cancer abbreviations. Cancers of interest are highlighted in colors

Article Snippet: Single cell transcriptomics datasets for LGG and SKCM cancer types were downloaded from the Broad Institute Single Cell Portal under accession number SCP271 ( ) and GEO Accession viewer under accession ID GSE72056 , respectively.

Techniques:

Multiple survival models identify key prognostic PANoptosis markers for LGG, KIRC and SKCM. ( A ) Forest plot for key PANoptosis genes whose high expression leads to a poor prognosis for LGG identified through univariate survival models. ( B ) PANoptosis genes with non-zero coefficients and the fraction of times they appeared during the 100 random runs of the GLMnet model for LGG. ( C ) Top 10 PANoptosis genes with highest prognostic relevance determined by the optimal RFS model for LGG. ( D ) Forest plot for key PANoptosis genes whose high expression leads to a poor prognosis for KIRC identified through univariate survival models. ( E ) PANoptosis genes with non-zero coefficients and the fraction of times they appeared during the 100 random runs of the GLMnet model for KIRC. ( F ) Top 10 PANoptosis genes with highest prognostic relevance determined by the optimal RFS model for KIRC. ( G ) Forest plot for key PANoptosis genes whose high expression leads to better prognosis for SKCM identified by univariate survival models. ( H ) PANoptosis genes with non-zero coefficients and the fraction of times they appeared during the 100 random runs of the GLMnet model for SKCM. ( I ) Top 10 PANoptosis genes with highest prognostic relevance determined by the optimal RFS model for SKCM. (A–I) Blue bars represent a negative coefficient (higher expression is beneficial for survival), and red bars represent a positive coefficient (higher expression is detrimental for survival). The orange boxes highlight the genes which are prognostic across the univariate, GLMNet and RFS survival models and were considered as the ‘Top’ PANoptosis markers. (B, C, E, F, H, I) The boxplots correspond to variable importance estimated using a subsampling approach.

Journal: NAR Cancer

Article Title: Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology

doi: 10.1093/narcan/zcac033

Figure Lengend Snippet: Multiple survival models identify key prognostic PANoptosis markers for LGG, KIRC and SKCM. ( A ) Forest plot for key PANoptosis genes whose high expression leads to a poor prognosis for LGG identified through univariate survival models. ( B ) PANoptosis genes with non-zero coefficients and the fraction of times they appeared during the 100 random runs of the GLMnet model for LGG. ( C ) Top 10 PANoptosis genes with highest prognostic relevance determined by the optimal RFS model for LGG. ( D ) Forest plot for key PANoptosis genes whose high expression leads to a poor prognosis for KIRC identified through univariate survival models. ( E ) PANoptosis genes with non-zero coefficients and the fraction of times they appeared during the 100 random runs of the GLMnet model for KIRC. ( F ) Top 10 PANoptosis genes with highest prognostic relevance determined by the optimal RFS model for KIRC. ( G ) Forest plot for key PANoptosis genes whose high expression leads to better prognosis for SKCM identified by univariate survival models. ( H ) PANoptosis genes with non-zero coefficients and the fraction of times they appeared during the 100 random runs of the GLMnet model for SKCM. ( I ) Top 10 PANoptosis genes with highest prognostic relevance determined by the optimal RFS model for SKCM. (A–I) Blue bars represent a negative coefficient (higher expression is beneficial for survival), and red bars represent a positive coefficient (higher expression is detrimental for survival). The orange boxes highlight the genes which are prognostic across the univariate, GLMNet and RFS survival models and were considered as the ‘Top’ PANoptosis markers. (B, C, E, F, H, I) The boxplots correspond to variable importance estimated using a subsampling approach.

Article Snippet: Single cell transcriptomics datasets for LGG and SKCM cancer types were downloaded from the Broad Institute Single Cell Portal under accession number SCP271 ( ) and GEO Accession viewer under accession ID GSE72056 , respectively.

Techniques: Expressing

Survival models built using key PANoptosis markers predict survival on independent test sets. ( A ) Comparison of AUC metric at t ∈ {2,4,5} years between Coxnet, GLMnet and RFS survival models for LGG. ( B ) Comparison of AUC metric at t ∈ {2,3,5} years between Coxnet, GLMnet and RFS survival models for KIRC. ( C ) Comparison of AUC metric at t ∈ {1,2,3} years between Coxnet, GLMnet and RFS models for SKCM.

Journal: NAR Cancer

Article Title: Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology

doi: 10.1093/narcan/zcac033

Figure Lengend Snippet: Survival models built using key PANoptosis markers predict survival on independent test sets. ( A ) Comparison of AUC metric at t ∈ {2,4,5} years between Coxnet, GLMnet and RFS survival models for LGG. ( B ) Comparison of AUC metric at t ∈ {2,3,5} years between Coxnet, GLMnet and RFS survival models for KIRC. ( C ) Comparison of AUC metric at t ∈ {1,2,3} years between Coxnet, GLMnet and RFS models for SKCM.

Article Snippet: Single cell transcriptomics datasets for LGG and SKCM cancer types were downloaded from the Broad Institute Single Cell Portal under accession number SCP271 ( ) and GEO Accession viewer under accession ID GSE72056 , respectively.

Techniques: Comparison

Single cell transcriptomics provides evidence for PANoptosis in individual cells in LGG and SKCM datasets. ( A ) Expression profiles of PANoptosis genes across different cell types in the LGG dataset. ( B ) PANoptosis activity across different cell types in the LGG dataset estimated using ssGSEA. ( C ) Expression profiles of PANoptosis genes across different cell types for the SKCM dataset. ( D ) PANoptosis activity across different cell types in the SKCM dataset estimated using ssGSEA.

Journal: NAR Cancer

Article Title: Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology

doi: 10.1093/narcan/zcac033

Figure Lengend Snippet: Single cell transcriptomics provides evidence for PANoptosis in individual cells in LGG and SKCM datasets. ( A ) Expression profiles of PANoptosis genes across different cell types in the LGG dataset. ( B ) PANoptosis activity across different cell types in the LGG dataset estimated using ssGSEA. ( C ) Expression profiles of PANoptosis genes across different cell types for the SKCM dataset. ( D ) PANoptosis activity across different cell types in the SKCM dataset estimated using ssGSEA.

Article Snippet: Single cell transcriptomics datasets for LGG and SKCM cancer types were downloaded from the Broad Institute Single Cell Portal under accession number SCP271 ( ) and GEO Accession viewer under accession ID GSE72056 , respectively.

Techniques: Single-cell Transcriptomics, Expressing, Activity Assay